Sobi to streamline nirsevimab contractual arrangements

Nirsevimab economics simplified through a new royalty agreement with Sanofi and the termination of the participation agreement with AstraZeneca

 

Alignment will provide Sobi benefit through... | April 9, 2023

Related Keywords

Stockholm ,Sweden ,United States ,Australia ,America ,Thomas Kudsk Larsen ,Sobi Investor Relations Team ,Astrazeneca ,For Sobi Media ,Swedish Orphan Biovitrum Ab Publ Stock Exchange ,News ,Information ,Press Release ,Nirsevimab ,Conomics ,Simplified ,Through ,Few ,Royalty ,Agreement ,Ith ,Sanofi ,End ,The ,Termination ,F ,Participation ,Hill ,Rovide ,Gobi ,Enefit Sobi Se0000872095 ,